Trial to evaluate effects of the intention to treat for insulin resistance (ITT-IR) to prevent cardiovascular events in early stages of diabetes

Not Applicable

Completed

• Conditions: Early stages of diabetes; Nutritional, Metabolic, Endocrine

• Registration Number: ISRCTN11215387
• Lead Sponsor: Wakayama Rosai Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2021-06-30
• Study Start: 2024-04-05
• Last Update Posted: 22 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 757

Inclusion Criteria

Diabetes patients visited outpatient clinic in Wakayama Rosai Hospital from April to June in 2016

Exclusion Criteria

Cannot continue to visit our outpatient clinic

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Measured using patient records at the end of study:<br>Percutaneous coronary intervention, carotid endarterectomy, carotid artery stenting, endovascular treatment, thromboendarterectomy, coronary artery bypass grafting, ablation, implantable cardioverter defibrillator, clipping for aneurysm of intracranial arteries, amputation from gangrene, non-fatal stroke, non-fatal myocardial infarction(MI), hemodialysis, frailty, dementia, hospitalization from heart failure, death from cardiovascular causes, death from renal failure, death from frailty)

Secondary Outcome Measures

Name	Time	Method
Measured using patient records at the end of study:<br>Hospitalization from complications or comorbidities, death)